CF
CGON icon

Corebridge Financial’s CG Oncology CGON Stock Holding History

Corebridge Financial’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,514
Closed -$649K – 533
2025
Q1 		$649K Sell
26,514
-66,675
-72% -$1.88M ﹤0.01% 1457
2024
Q4 		$2.67M Sell
93,189
-42,440
-31% -$1.45M 0.01% 912
2024
Q3 		$5.12M Sell
135,629
-171,657
-56% -$6.02M 0.03% 728
2024
Q2 		$9.7M Buy
+307,286
New +$10.7M 0.05% 406

Other funds holding CGON

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corebridge Financial's CGON Position: Q2 2025 in Review

Corebridge Financial sold out of CG Oncology (CGON) in Q2 2025, closing a stake of 26,514 shares — an estimated $649K sold.

Corebridge Financial first reported a position in CGON in Q2 2024 and held it in 4 quarters. The position peaked at $9.7M in Q2 2024. 162 funds tracked by Wall St. Rank hold CGON as of Q2 2025.

  • Corebridge Financial reported no remaining CG Oncology position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 26,514 CG Oncology shares in Q2 2025, an estimated $649K.
  • Corebridge Financial first reported a position in CG Oncology in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's CG Oncology position peaked at $9.7M in Q2 2024.
  • 162 funds tracked by Wall St. Rank held CG Oncology as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.